• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I 型干扰素信号通路保护小鼠免受致死性 SARS-CoV-2 神经入侵。

Type I IFN Signaling Protects Mice from Lethal SARS-CoV-2 Neuroinvasion.

机构信息

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX; and.

Department of Experimental Pathology, University of Texas Medical Branch, Galveston, TX.

出版信息

Immunohorizons. 2022 Oct 11;6(10):716-721. doi: 10.4049/immunohorizons.2200065.

DOI:10.4049/immunohorizons.2200065
PMID:36220188
Abstract

Multiple organ damage is common in patients with severe COVID-19, even though the underlying pathogenic mechanisms remain unclear. Acute viral infection typically activates type I IFN (IFN-I) signaling. The antiviral role of IFN-I is well characterized in vitro. However, our understanding of how IFN-I regulates host immune response to SARS-CoV-2 infection in vivo is incomplete. Using a human ACE2-transgenic mouse model, we show in the present study that IFN-I receptor signaling is essential for protection against the acute lethality of SARS-CoV-2 in mice. Interestingly, although IFN-I signaling limits viral replication in the lung, the primary infection site, it is dispensable for efficient viral clearance at the adaptive phase of SARS-CoV-2 infection. Conversely, we found that in the absence of IFN-I receptor signaling, the extreme animal lethality is consistent with heightened infectious virus and prominent pathological manifestations in the brain. Taken together, our results in this study demonstrate that IFN-I receptor signaling is required for restricting virus neuroinvasion, thereby mitigating COVID-19 severity.

摘要

多器官损伤在重症 COVID-19 患者中很常见,尽管其潜在的发病机制仍不清楚。急性病毒感染通常会激活 I 型干扰素(IFN-I)信号。IFN-I 的抗病毒作用在体外得到了很好的描述。然而,我们对于 IFN-I 如何调节宿主对 SARS-CoV-2 感染的免疫反应的理解还不完全。本研究使用人 ACE2 转基因小鼠模型表明,IFN-I 受体信号对于保护小鼠免受 SARS-CoV-2 的急性致死性至关重要。有趣的是,尽管 IFN-I 信号限制了肺部(主要感染部位)的病毒复制,但在 SARS-CoV-2 感染的适应性阶段,它对于有效清除病毒是可有可无的。相反,我们发现,在缺乏 IFN-I 受体信号的情况下,极高的动物致死率与脑中病毒载量增加和明显的病理表现一致。总之,我们在这项研究中的结果表明,IFN-I 受体信号对于限制病毒向神经组织的入侵是必需的,从而减轻 COVID-19 的严重程度。

相似文献

1
Type I IFN Signaling Protects Mice from Lethal SARS-CoV-2 Neuroinvasion.I 型干扰素信号通路保护小鼠免受致死性 SARS-CoV-2 神经入侵。
Immunohorizons. 2022 Oct 11;6(10):716-721. doi: 10.4049/immunohorizons.2200065.
2
Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway.血管紧张素转换酶 2 通过拮抗 I 型干扰素诱导及其下游信号通路增强 SARS-CoV-2 感染。
mSphere. 2022 Aug 31;7(4):e0021122. doi: 10.1128/msphere.00211-22. Epub 2022 Jul 12.
3
Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.小胶质细胞在 K18-Human ACE2 转基因小鼠中枢神经系统感染后并不限制 SARS-CoV-2 的复制。
J Virol. 2022 Feb 23;96(4):e0196921. doi: 10.1128/jvi.01969-21. Epub 2021 Dec 22.
4
The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.K18-Human ACE2 转基因小鼠模型对 SARS-CoV-2 病毒感染剂量的反应可重现非重症和重症 COVID-19。
J Virol. 2022 Jan 12;96(1):e0096421. doi: 10.1128/JVI.00964-21. Epub 2021 Oct 20.
5
Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection.利用慢病毒 hACE2 载体在小鼠中模拟 SARS-CoV-2 感染,推断出两种针对 SARS-CoV-2 感染的免疫反应模式。
Viruses. 2021 Dec 21;14(1):11. doi: 10.3390/v14010011.
6
Transgenic mouse models support a protective role of type I IFN response in SARS-CoV-2 infection-related lung immunopathology and neuroinvasion.转基因小鼠模型支持 I 型干扰素反应在 SARS-CoV-2 感染相关肺部免疫病理学和神经侵袭中的保护作用。
Cell Rep. 2023 Nov 28;42(11):113275. doi: 10.1016/j.celrep.2023.113275. Epub 2023 Oct 23.
7
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.SARS-CoV-2 引起人类 ACE2 基因敲入小鼠肺部感染但不引起严重疾病。
J Virol. 2022 Jan 12;96(1):e0151121. doi: 10.1128/JVI.01511-21. Epub 2021 Oct 20.
8
Ginseng Protects ACE2-Transgenic Mice from SARS-CoV-2 Infection.人参保护 ACE2 转基因小鼠免受 SARS-CoV-2 感染。
Front Biosci (Landmark Ed). 2022 Jun 6;27(6):180. doi: 10.31083/j.fbl2706180.
9
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.一种适应 SARS-CoV-2 的小鼠模型,用于测试 COVID-19 对策。
Nature. 2020 Oct;586(7830):560-566. doi: 10.1038/s41586-020-2708-8. Epub 2020 Aug 27.
10
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.K18- 和 CAG-hACE2 转基因小鼠模型与 SARS-CoV-2:对神经退行性变研究的启示。
Molecules. 2022 Jun 28;27(13):4142. doi: 10.3390/molecules27134142.

引用本文的文献

1
Toll-like receptor 7 (TLR7)-mediated antiviral response protects mice from lethal SARS-CoV-2 infection.Toll样受体7(TLR7)介导的抗病毒反应可保护小鼠免受致命的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染。
J Virol. 2025 May 20;99(5):e0166824. doi: 10.1128/jvi.01668-24. Epub 2025 Mar 31.
2
The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication.感染时肺部的炎症微环境决定了对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)复制的固有控制。
bioRxiv. 2024 Mar 27:2024.03.27.586885. doi: 10.1101/2024.03.27.586885.
3
Co-infection of mice with SARS-CoV-2 and limits early viral replication but does not affect mycobacterial loads.
SARS-CoV-2 与 共感染限制了早期病毒复制,但不影响分枝杆菌负荷。
Front Immunol. 2023 Sep 1;14:1240419. doi: 10.3389/fimmu.2023.1240419. eCollection 2023.